Defining the in vivo characteristics of acute myeloid leukemia cells behavior by intravital imaging

Immunol Cell Biol. 2019 Feb;97(2):229-235. doi: 10.1111/imcb.12216. Epub 2018 Dec 13.

Abstract

The majority of acute myeloid leukemia (AML) patients have a poor response to conventional chemotherapy. The survival of chemoresistant cells is thought to depend on leukemia-bone marrow (BM) microenvironment interactions, which are not well understood. The CXCL12/CXCR4 axis has been proposed to support AML growth but was not studied at the single AML cell level. We recently showed that T-cell acute lymphoblastic leukemia (T-ALL) cells are highly motile in the BM; however, the characteristics of AML cell migration within the BM remain undefined. Here, we characterize the in vivo migratory behavior of AML cells and their response to chemotherapy and CXCR4 antagonism, using high-resolution 2-photon and confocal intravital microscopy of mouse calvarium BM and the well-established MLL-AF9-driven AML mouse model. We used the Notch1-driven T-ALL model as a benchmark comparison and AMD3100 for CXCR4 antagonism experiments. We show that AML cells are migratory, and in contrast with T-ALL, chemoresistant AML cells become less motile. Moreover, and in contrast with T-ALL, the in vivo exploratory behavior of expanding and chemoresistant AML cells is unaffected by AMD3100. These results expand our understanding of AML cells-BM microenvironment interactions, highlighting unique traits of leukemia of different lineages.

Keywords: Acute myeloid leukemia cells; chemokines; intravital imaging; lymphoblastic leukemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Benzylamines
  • Bone Marrow / metabolism
  • Bone Marrow / pathology
  • Cell Line, Tumor
  • Cell Movement*
  • Chemokine CXCL12 / metabolism*
  • Cyclams
  • Drug Resistance, Neoplasm / drug effects
  • Heterocyclic Compounds / antagonists & inhibitors*
  • Heterocyclic Compounds / metabolism
  • Intravital Microscopy
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / metabolism
  • Leukemia, Myeloid, Acute / pathology*
  • Mice
  • Microscopy, Confocal
  • Microscopy, Fluorescence, Multiphoton
  • Receptors, CXCR4 / metabolism*
  • Tumor Microenvironment

Substances

  • Antineoplastic Agents
  • Benzylamines
  • Chemokine CXCL12
  • Cyclams
  • Heterocyclic Compounds
  • Receptors, CXCR4
  • plerixafor